ON THE MECHANISMS OF DRUG RESISTANCE IN HIV-1 RT

被引:0
|
作者
Sharma, B. [1 ]
机构
[1] Univ Allahabad, Allahabad 211002, Uttar Pradesh, India
关键词
D O I
10.1136/sextrans-2013-051184.0236
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
P1.015
引用
收藏
页码:A78 / A78
页数:1
相关论文
共 50 条
  • [31] Recent trends in HIV-1 drug resistance
    Siliciano, Janet D.
    Siliciano, Robert F.
    CURRENT OPINION IN VIROLOGY, 2013, 3 (05) : 487 - 494
  • [32] Pretreatment HIV-1 drug resistance in Africa
    Hamers, Raph L.
    Kityo, Cissy
    Sigaloff, Kim C. E.
    de Wit, Tobias F. Rinke
    LANCET INFECTIOUS DISEASES, 2013, 13 (06): : 476 - 476
  • [33] SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
    DECLERCQ, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 673 - 673
  • [34] HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria
    Oluniyi, Paul E.
    Ajogbasile, Fehintola, V
    Zhou, Shuntai
    Fred-Akintunwa, Iyanuoluwa
    Polyak, Christina S.
    Ake, Julie A.
    Tovanabutra, Sodsai
    Iroezindu, Michael
    Rolland, Morgane
    Happi, Christian T.
    AIDS, 2022, 36 (01) : 137 - 146
  • [35] HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde
    Goncalves, Paloma
    Barreto, Jorge
    Santos, Menilita
    Leal, Silvania
    Marcelino, Jose
    Abecasis, Ana
    Palladino, Claudia
    Taveira, Nuno
    AIDS, 2024, 38 (08) : 1101 - 1110
  • [36] Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C
    Cunha, Rodrigo D.
    Abreu, Celina M.
    Gonzalez, Luis M. F.
    Nijhuis, Monique
    de Jong, Dorien
    Aguiar, Renato S.
    Afonso, Adriana O.
    Brindeiro, Rodrigo M.
    Tanuri, Amilcar
    PLOS ONE, 2012, 7 (10):
  • [37] HIV-1 drug-resistance and drug-dependence
    Chris Baldwin
    Ben Berkhout
    Retrovirology, 4
  • [38] HIV-1 drug-resistance and drug-dependence
    Baldwin, Chris
    Berkhout, Ben
    RETROVIROLOGY, 2007, 4 (1)
  • [39] HIV-1 reverse transcriptase (RT) mutations for HIV drug resistance surveillance and epidemiology: application to published studies of primary infection
    Shafer, R. W.
    Rhee, S. Y.
    Pillay, D.
    Dalwani, A.
    Miller, V.
    Sandstrom, P.
    Schapiro, J. M.
    Kuritzkes, D. R.
    Bennett, D.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S128 - S128
  • [40] Is there cross talk between HIV-1 5′RT drug resistance mutations (DRMs) and connection/RNase H (3′RT) mutations?
    Rhee, S. Y.
    Varghese, V.
    Winters, M. A.
    Holodniy, M.
    Shafer, R. W.
    ANTIVIRAL THERAPY, 2013, 18 : A67 - A67